
Selective zzso zzso have now been established as a standard of care option for patients diagnosed with zzso melanoma whose tumors carry a zzso zzso Their successful development represents a milestone in the treatment of this disease, and has the potential to impact therapy for other zzso as zzso The use of these agents, however, has introduced a number of critical questions about the optimal use and selection of patients for zzso inhibitor zzso This review discusses the current status of zzso inhibitor clinical development, the zzso features of zzso melanoma, as well as strategies for overcoming zzso 

